# EQT to sell Clinical Innovations to LABORIE for USD 525 million

EQT Mid Market US and EQT Mid Market Asia III have agreed to sell Clinical Innovations, a medical device manufacturer, to LABORIE Medical Technologies for an enterprise value of USD 525 million.

- Type: Acquisition
- Announced: 2019-12-20
- Where: Salt Lake City, Utah, United States
- Value: $525.0M
- Status: announced
- Products: medical devices for Labor & Delivery and Neonatal Intensive Care
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [EQT](https://endata.com/companies/3219.md) (partner)
- [EQT Mid Market US](https://endata.com/companies/22988.md) (partner)
- [Laborie Medical Technologies](https://endata.com/companies/30706.md) (acquirer)
- [Clinical Innovations](https://endata.com/companies/34128.md) (target)
- [EQT Mid Market Asia III](https://endata.com/companies/44083.md) (partner)

## Sources

- [eqtgroup.com](https://eqtgroup.com/news/eqt-to-sell-clinical-innovations-2019-12-20), 2019-12-20: "EQT Mid Market US and EQT Mid Market Asia III to sell Clinical Innovations to LABORIE for an Enterprise Value of USD 525m"
- [biospace.com](https://www.biospace.com/clinical-innovations-to-be-acquired-by-laborie-medical-technologies), 2019-12-20: "Clinical Innovations has signed a definitive agreement to be acquired by LABORIE Medical Technologies for an enterprise value of $525M."
- [mpo-mag.com](https://www.mpo-mag.com/breaking-news/laborie-medical-technologies-to-acquire-clinical-innovations/), 2020-01-02: "Acquiring Clinical Innovations marks an important step in the evolution of our business and our continued investment in market-leading technologies for high-growth medical specialties."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.